IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
556.93
+11.07 (2.03%)
Aug 21, 2026, 4:00 PM EDT - Market closed
IDEXX Laboratories Revenue
IDEXX Laboratories had revenue of $1.22B in the quarter ending June 30, 2026, with 9.66% growth. This brings the company's revenue in the last twelve months to $4.55B, up 12.77% year-over-year. In the year 2025, IDEXX Laboratories had annual revenue of $4.30B with 10.42% growth.
Revenue (ttm)
$4.55B
Revenue Growth
+12.77%
P/S Ratio
9.64
Revenue / Employee
$413,929
Employees
11,000
Market Cap
43.88B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.30B | 406.20M | 10.42% |
| Dec 31, 2024 | 3.90B | 236.55M | 6.46% |
| Dec 31, 2023 | 3.66B | 293.63M | 8.72% |
| Dec 31, 2022 | 3.37B | 151.96M | 4.73% |
| Dec 31, 2021 | 3.22B | 508.71M | 18.79% |
| Dec 31, 2020 | 2.71B | 299.75M | 12.45% |
| Dec 31, 2019 | 2.41B | 193.67M | 8.75% |
| Dec 31, 2018 | 2.21B | 244.18M | 12.40% |
| Dec 31, 2017 | 1.97B | 193.64M | 10.91% |
| Dec 31, 2016 | 1.78B | 173.53M | 10.83% |
| Dec 31, 2015 | 1.60B | 116.09M | 7.81% |
| Dec 31, 2014 | 1.49B | 108.75M | 7.90% |
| Dec 31, 2013 | 1.38B | 83.72M | 6.47% |
| Dec 31, 2012 | 1.29B | 74.65M | 6.13% |
| Dec 31, 2011 | 1.22B | 115.30M | 10.45% |
| Dec 31, 2010 | 1.10B | 71.76M | 6.96% |
| Dec 31, 2009 | 1.03B | 7.60M | 0.74% |
| Dec 31, 2008 | 1.02B | 101.48M | 11.00% |
| Dec 31, 2007 | 922.56M | 183.44M | 24.82% |
| Dec 31, 2006 | 739.12M | 101.02M | 15.83% |
| Dec 31, 2005 | 638.10M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 16.98B |
| Labcorp Holdings | 14.35B |
| Quest Diagnostics | 11.56B |
| Agilent Technologies | 7.23B |
| Waters | 4.64B |
| Illumina | 4.49B |
| Mettler-Toledo International | 4.13B |
| Charles River Laboratories International | 4.00B |
IDXX News
- 10 days ago - IDEXX Laboratories Transcript: Investor Day 2026 - Transcripts
- 10 days ago - IDEXX Laboratories Slides: FY 2026 - Filings
- 12 days ago - Idexx Laboratories announces launch of Catalyst proBNP Test - TheFly
- 12 days ago - IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test - Business Wire
- 12 days ago - Idexx Laboratories price target lowered to $710 from $800 at Barclays - TheFly
- 18 days ago - Idexx Laboratories price target raised to $670 from $620 at UBS - TheFly
- 18 days ago - Idexx Laboratories price target raised to $670 from $650 at Citi - TheFly
- 19 days ago - Idexx Laboratories reports Q2 EPS $4.27, consensus $3.93 - TheFly